Cargando…

Intrinsic Myogenic Potential of Skeletal Muscle-Derived Pericytes from Patients with Myotonic Dystrophy Type 1

Pericytes are multipotent, vessel-associated progenitors that exhibit high proliferative capacity, can cross the blood-muscle barrier, and have the ability to home to muscle tissue and contribute to myogenesis. Consequently, pericyte-based therapies hold great promise for muscular dystrophies. A com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ausems, Cornelia Rosanne Maria, Raaijmakers, Renée Henrica Lamberta, van den Broek, Walterus Johannes Antonius Adriana, Willemse, Marieke, van Engelen, Baziel Gerardus Maria, Wansink, Derick Gert, van Bokhoven, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804802/ https://www.ncbi.nlm.nih.gov/pubmed/31649961 http://dx.doi.org/10.1016/j.omtm.2019.09.002

Ejemplares similares

Systemic cell therapy for muscular dystrophies: The ultimate transplantable muscle progenitor cell and current challenges for clinical efficacy
por: Ausems, C. Rosanne M., et al.
Publicado: (2020)

CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities
por: Raaijmakers, Renée H.L., et al.
Publicado: (2019)

Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)n Repeat
por: André, Laurène M., et al.
Publicado: (2019)

Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy
por: André, Laurène M., et al.
Publicado: (2018)

Cell Membrane Integrity in Myotonic Dystrophy Type 1: Implications for Therapy
por: González-Barriga, Anchel, et al.
Publicado: (2015)

Somatic CTG•CAG repeat instability in a mouse model for myotonic dystrophy type 1 is associated with changes in cell nuclearity and DNA ploidy
por: van den Broek, Walther JAA, et al.
Publicado: (2007)

CRISPR/Cas9-Induced (CTG⋅CAG)(n) Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing
por: van Agtmaal, Ellen L., et al.
Publicado: (2017)

A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle
por: Gudde, Anke E. E. G., et al.
Publicado: (2016)

Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial
por: van Engelen, Baziel
Publicado: (2015)

(CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage
por: André, Laurène M., et al.
Publicado: (2019)

Living with myotonic dystrophy; what can be learned from couples? a qualitative study
por: Cup, Edith HC, et al.
Publicado: (2011)

Lower extremity muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI
por: Heskamp, Linda, et al.
Publicado: (2019)

High disease impact of myotonic dystrophy type 2 on physical and mental functioning
por: Tieleman, Alide A., et al.
Publicado: (2011)

Human brain pathology in myotonic dystrophy type 1: A systematic review
por: Weijs, Ralf, et al.
Publicado: (2021)

Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1
por: Nieuwenhuis, Sylvia, et al.
Publicado: (2019)

Clinical Outcome Evaluations and CBT Response Prediction in Myotonic Dystrophy
por: van As, Daniël, et al.
Publicado: (2021)

Overweight Is an Independent Risk Factor for Reduced Lung Volumes in Myotonic Dystrophy Type 1
por: Seijger, Charlotte G. W., et al.
Publicado: (2016)

Structural white matter networks in myotonic dystrophy type 1
por: van Dorst, Maud, et al.
Publicado: (2018)

A comprehensive atlas of fetal splicing patterns in the brain of adult myotonic dystrophy type 1 patients
por: Degener, Max J F, et al.
Publicado: (2022)

Design and Analysis of Effects of Triplet Repeat Oligonucleotides in Cell Models for Myotonic Dystrophy
por: González-Barriga, Anchel, et al.
Publicado: (2013)

Electrocardiographic predictors of infrahissian conduction disturbances in myotonic dystrophy type 1
por: Joosten, Isis B T, et al.
Publicado: (2020)

Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review
por: Landfeldt, Erik, et al.
Publicado: (2019)

Antisense transcription of the myotonic dystrophy locus yields low-abundant RNAs with and without (CAG)n repeat
por: Gudde, Anke E. E. G., et al.
Publicado: (2017)

Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1)
por: Nieuwenhuis, Sylvia, et al.
Publicado: (2022)

Block or degrade? Balancing on- and off-target effects of antisense strategies against transcripts with expanded triplet repeats in DM1
por: El Boujnouni, Najoua, et al.
Publicado: (2023)

A Tail-Anchored Myotonic Dystrophy Protein Kinase Isoform Induces Perinuclear Clustering of Mitochondria, Autophagy, and Apoptosis
por: Oude Ophuis, Ralph J. A., et al.
Publicado: (2009)

An evaluation of 24 h Holter monitoring in patients with myotonic dystrophy type 1
por: Joosten, Isis B T, et al.
Publicado: (2022)

Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2
por: Kamsteeg, Erik-Jan, et al.
Publicado: (2012)

Myotonic dystrophy type 1: A comparison between the adult‐ and late‐onset subtype
por: Joosten, Isis B.T., et al.
Publicado: (2022)

Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort
por: Cumming, Sarah A., et al.
Publicado: (2019)

Associations Between Variant Repeat Interruptions and Clinical Outcomes in Myotonic Dystrophy Type 1
por: Wenninger, Stephan, et al.
Publicado: (2021)

Potassium currents in human myogenic cells from healthy and congenital myotonic dystrophy foetuses
por: Nurowska, Ewa, et al.
Publicado: (2009)

Effects of shared medical appointments on quality of life and cost-effectiveness for patients with a chronic neuromuscular disease. Study protocol of a randomized controlled trial
por: Seesing, Femke M, et al.
Publicado: (2011)

Expanded CUG repeats in DMPK transcripts adopt diverse hairpin conformations without influencing the structure of the flanking sequences
por: van Cruchten, Remco T.P., et al.
Publicado: (2019)

Care for capabilities: Implementing the capability approach in rehabilitation of patients with neuromuscular diseases. Study protocol of the controlled before-after ReCap-NMD study
por: Bloemen, Bart, et al.
Publicado: (2021)

Patients’ views on Self-administration of Medication during hospitalisation: a mixed-methods study
por: van Herpen-Meeuwissen, Loes Johanna Maria, et al.
Publicado: (2022)

Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations
por: Voermans, N. C., et al.
Publicado: (2019)

Prevalence and determinants of medication administration errors in clinical wards: A two‐centre prospective observational study
por: Jessurun, Janique Gabriëlle, et al.
Publicado: (2022)

Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells
por: Dastidar, Sumitava, et al.
Publicado: (2018)

Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy
por: Greco, Anna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0vqkfatiku9sdeppjbltb96f9h